Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders

Oct 16, 2015British journal of clinical pharmacology

Using mTOR and Cell Recycling Processes to Treat Brain Diseases That Cause Memory and Movement Problems

AI simplified

Abstract

More than 30 million individuals worldwide are affected by neurodegenerative disorders.

  • Neurodegenerative disorders include Alzheimer's, Parkinson's, Huntington's diseases, epilepsy, stroke, and trauma.
  • The mTOR protein kinase is involved in crucial cellular processes such as programmed cell death and neuronal cell development.
  • Control of mTOR signaling may influence neuronal stem cell development, precursor cell differentiation, and cell survival.
  • The relationship between apoptosis and autophagy is complex and significant in the context of mTOR functions.
  • Further understanding of mTOR pathways is essential for developing new treatments for neurodegenerative diseases.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free